These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11017834)

  • 1. Dramatic improvement of renal dysfunction in a human immunodeficiency virus-infected woman treated with highly active antiretroviral therapy.
    Chemlal K; Nochy D; Kenouch S; Joly V; Carbon C
    Clin Infect Dis; 2000 Sep; 31(3):805-6. PubMed ID: 11017834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.
    Kulkosky J; Nunnari G; Otero M; Calarota S; Dornadula G; Zhang H; Malin A; Sullivan J; Xu Y; DeSimone J; Babinchak T; Stern J; Cavert W; Haase A; Pomerantz RJ
    J Infect Dis; 2002 Nov; 186(10):1403-11. PubMed ID: 12404155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.
    Koyalta D; Charpentier C; Beassamda J; Rey E; Si-Mohamed A; Djemadji-Oudjeil N; Bélec L
    Clin Infect Dis; 2009 Jul; 49(1):155-9. PubMed ID: 19480574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.
    Kulkosky J; Pomerantz RJ
    Clin Infect Dis; 2002 Dec; 35(12):1520-6. PubMed ID: 12471572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant.
    Feiterna-Sperling C; Hüseman D; Timme J; Bührer C; Obladen M
    Pediatr Infect Dis J; 2008 Jun; 27(6):564-7. PubMed ID: 18449067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated nephropathy in the era of antiretroviral therapy.
    Wyatt CM; Klotman PE
    Am J Med; 2007 Jun; 120(6):488-92. PubMed ID: 17524746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen.
    Tanuma J; Ishizaki A; Gatanaga H; Kikuchi Y; Kimura S; Hiroe M; Oka S
    Clin Infect Dis; 2003 Oct; 37(7):e109-11. PubMed ID: 13130421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients.
    Jensen-Fangel S; Pedersen L; Pedersen C; Larsen CS; Tauris P; Møller A; Sørensen HT; Obel N
    Clin Infect Dis; 2002 Dec; 35(12):1541-8. PubMed ID: 12471575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
    Nuesch R; Ananworanich J; Sirivichayakul S; Ubolyam S; Siangphoe U; Hill A; Cooper D; Lange J; Phanuphak P; Ruxrungtham K
    Clin Infect Dis; 2005 Mar; 40(5):728-34. PubMed ID: 15714420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment interruptions in HIV-infected subjects.
    Bongiovanni M; Casana M; Tincati C; d'Arminio Monforte A
    J Antimicrob Chemother; 2006 Sep; 58(3):502-5. PubMed ID: 16816398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological recovery despite virological failure is independent of human immunodeficiency virus-type 1 resistant mutants in children receiving highly active antiretroviral therapy.
    Chiappini E; Galli L; Zazzi M; de Martino M
    J Med Virol; 2003 Aug; 70(4):506-12. PubMed ID: 12794711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 and HIV-Associated Nephropathy 25 Years Later.
    Wyatt CM; Klotman PE
    Clin J Am Soc Nephrol; 2007 Jul; 2 Suppl 1():S20-4. PubMed ID: 17699507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2.
    Rodés B; Toro C; Jiménez V; Soriano V
    Clin Infect Dis; 2005 Jul; 41(2):e19-21. PubMed ID: 15983906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.
    Simonelli C; Zanussi S; Cinelli R; Dal Maso L; Di Gennaro G; D'Andrea M; Nasti G; Spina M; Vaccher E; De Paoli P; Tirelli U
    Clin Infect Dis; 2003 Sep; 37(6):820-7. PubMed ID: 12955644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
    Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy in the treatment of HIV-associated nephropathy.
    Atta MG; Gallant JE; Rahman MH; Nagajothi N; Racusen LC; Scheel PJ; Fine DM
    Nephrol Dial Transplant; 2006 Oct; 21(10):2809-13. PubMed ID: 16864598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy.
    Santin M; Alcaide F
    Int J Tuberc Lung Dis; 2003 Jul; 7(7):673-7. PubMed ID: 12870689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.